Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Health Focus.
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
GlobeNewswire, Inc.
·
August 25, 2025
Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian...
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
GlobeNewswire, Inc.
·
August 21, 2025
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical,...
Whole Health at VA Pittsburgh
U.S. Department of Veterans Affairs
·
August 11, 2025
Enter through the front doors of the H. John Heinz III campus of the VA Pittsburgh Healthcare System on any given day and you might see Veterans doing yoga, tai chi, weightlifting and any number of other physical activities. What you’re really...
Oculis to Participate in Upcoming September Investor Conferences
GlobeNewswire, Inc.
·
August 28, 2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant...
The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025
GlobeNewswire, Inc.
·
August 28, 2025
STUDIO CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma campaign, centering on the...
Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
GlobeNewswire, Inc.
·
July 28, 2025
CELEBRATION, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare diseases, announced the company submitted...
LifeVantage To Open Iceland Market
GlobeNewswire, Inc.
·
July 24, 2025
SALT LAKE CITY, July 24, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced its upcoming launch...
Live Whole Health #281: Take a stand!
U.S. Department of Veterans Affairs
·
July 14, 2025
Ready to take a stand? Many older adults spend between 9 and 13 hours a day sitting and they struggle to add physical movement and mobility into their lives. As we age, even the day-to-day activities such as reaching for a can on a shelf, walking...
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
GlobeNewswire, Inc.
·
July 1, 2025
REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
June 23, 2025
REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered...
Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics
EIN Presswire
·
August 19, 2025
Icelandic venture capital firm Brunnur Ventures leads funding round to support development of breakthrough lipid nanoparticle delivery technologies BROOKLINE, MA, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Axelyf, Inc., a biotechnology...
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
GlobeNewswire, Inc.
·
June 6, 2025
REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
GlobeNewswire, Inc.
·
June 2, 2025
REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
GlobeNewswire, Inc.
·
May 28, 2025
Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programs The agreement includes proposed biosimilars to Ilaris® (canakinumab), Kesimpta® (ofatumumab)...
Icelandirect Partners with Rbionutrix to Ensure Consistent Supply of High-Quality Fish Oil
EIN Presswire
·
April 9, 2025
Icelandirect partners with Rbionutrix to ensure a steady, sustainable supply of high-quality fish oil for global omega-3 customers. CLIFTON, NJ, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- Icelandirect, a leading supplier of bulk and...
Dairy Council of California Celebrates June is Dairy Month with a Global Spotlight on Health, Culture, and Community
GlobeNewswire, Inc.
·
May 28, 2025
SACRAMENTO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Each June, the nation comes together to celebrate National Dairy Month—also known as June is Dairy Month—honoring the hard work and dedication of the dairy farm families and the dairy community...
Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada
GlobeNewswire, Inc.
·
May 9, 2025
REYKJAVIK, Iceland, May 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the BofA...
Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025
GlobeNewswire, Inc.
·
May 7, 2025
REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued a statement on the...
Oculis Reports Q2 2025 Financial Results and Provides Company Update
GlobeNewswire, Inc.
·
August 21, 2025
Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and neuro-ophthalmology OCS-01: Both pivotal Ph3 DIAMOND trials are fully enrolled, with topline results expected in Q2 2026 for the first potential eye drop to treat...
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
GlobeNewswire, Inc.
·
April 15, 2025
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) who are apolipoprotein E ε4 (ApoE ε4*)...